Skinvisible (SKVI) EV to FCF (2010 - 2026)
Skinvisible's (SKVI) quarterly EV to FCF came in at 523.3 in Q2 2026, up 429.6% year-over-year from 98.81 in Q2 2025, and up 133.21% quarter-over-quarter from 1575.58 in Q1 2026.
Analysis
Skinvisible (SKVI) EV to FCF (2010 - 2026) Analysis & Trends
Skinvisible has disclosed EV to FCF across 17 years of filings, most recently posting 523.3 for Q2 2026.
- In Q2 2026, EV to FCF rose 429.6% year-over-year to 523.3; the TTM figure through Jun 2026 stood at 294.57 (up 1520.69% YoY), while the FY2025 annual figure was 29.19, down 28.36% from the prior year.
- EV to FCF came in at 523.3 for Q2 2026 at Skinvisible, up from 1575.58 in the prior quarter.
- In the past five years, EV to FCF ranged from a high of 1542.73 in Q3 2025 to a low of 1575.58 in Q1 2026.
- Average EV to FCF over 5 years is 7.91, with a median of 22.38 recorded in 2024.
- Year-over-year, EV to FCF surged 759.63% in 2025 and tumbled 1501.41% in 2026.
- Over 5 years, EV to FCF stood at 8.09 in 2022, then tumbled by 1064.76% to 94.28 in 2023, then dropped by 12.73% to 106.28 in 2024, then jumped by 690.88% to 627.98 in 2025, then slipped by 16.67% to 523.3 in 2026.
- Per Business Quant data, the three most recent EV to FCF figures were 523.3 in Q2 2026, 1575.58 in Q1 2026, and 627.98 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.23 Bn | 627.47 Bn | 17.26 Bn |
| 2 | AbbVie | 443.69 Bn | 437.12 Bn | 12.70 Bn |
| 3 | Merck | 368.29 Bn | 361.15 Bn | 12.21 Bn |
| 4 | Novartis Ag | 270.18 Bn | 262.49 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.93 Bn | 45.55 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - |
| 8 | Incyte | 25.21 Bn | 20.68 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.11 Bn | 18.44 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 523.30 |
| Mar 31, 2026 | -1,575.58 |
| Dec 31, 2025 | 627.98 |
| Sep 30, 2025 | 1,542.73 |
| Jun 30, 2025 | -158.77 |
| Mar 31, 2025 | -98.39 |
| Dec 31, 2024 | -106.28 |
| Sep 30, 2024 | -233.88 |
| Jun 30, 2024 | -130.31 |
| Mar 31, 2024 | -25.20 |
| Dec 31, 2023 | -94.28 |
| Sep 30, 2023 | -65.82 |
| Jun 30, 2023 | -17.60 |
| Mar 31, 2023 | -6.39 |
| Dec 31, 2022 | -8.09 |
| Sep 30, 2022 | -19.57 |
| Jun 30, 2022 | 2.34 |
| Mar 31, 2022 | -13.80 |
| Dec 31, 2021 | 6.65 |
| Sep 30, 2021 | 6.81 |